Search Results - "Burge, Russel T"

Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom by Pierce, Evangeline J., Burge, Russel T., Hirst, Alex J., Fox, Aimée M., Suokas, Anu K., Yi, Yunni

“…Introduction Atopic dermatitis is associated with intense itch, which has been shown to cause sleep disruption that significantly impacts the lives of patients…”
Get full text

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan by Macey, Jake, Kitchen, Helen, Aldhouse, Natalie V. J., Burge, Russel T., Edson-Heredia, Emily, McCollam, Jill S., Isaka, Yoshitaka, Torisu-Itakura, Hitoe

“…Introduction The content validity and treatment success thresholds of clinical outcome assessments (COAs) for alopecia areata (AA)—including the Alopecia…”
Get full text

Osteoporosis and treatments in Japan: management for preventing subsequent fractures by Nojiri, Shuko, Burge, Russel T., Flynn, Jennifer A., Foster, Shonda A., Sowa, Hideaki

“…Prevalent fractures are major contributors to an increased risk of subsequent fractures, particularly in people with osteoporosis. While many studies have been…”
Get full text

Adherence and Persistence with Once-Daily Teriparatide in Japan : A Retrospective, Prescription Database, Cohort Study by Tanaka, Ikuko, Sato, Masayo, Sugihara, Tomoko, Faries, Douglas E., Nojiri, Shuko, Graham-Clarke, Peita, Flynn, Jennifer A., Burge, Russel T.

“…Adherence and persistence with osteoporosis treatments are essential for reducing fracture risk. Once-daily teriparatide is available in Japan for treating…”
Get full text

Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review by Murage, Mwangi J, Tongbram, Vanita, Feldman, Steven R, Malatestinic, William N, Larmore, Cynthia J, Muram, Talia M, Burge, Russel T, Bay, Charles, Johnson, Nicole, Clifford, Sarah, Araujo, Andre B

“…Proper adherence and persistence to medications are crucial for better quality of life and improved outcomes in rheumatoid arthritis (RA), psoriasis (PsO), and…”
Get full text

Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas by Gottlieb, Alice B, Armstrong, April, Blauvelt, Andrew, Griffiths, Christopher E M, Pinter, Andreas, Gooderham, Melinda, Lomaga, Mark, Burge, Russel T, Konicek, Bruce W, McDonald, Meghan Feely, See, Kyoungah, McKean-Matthews, Missy, Mabuchi, Tomotaka

“…Psoriasis involving challenging body areas, such as the scalp, face, palmoplantar surfaces, or nails, can be challenging to treat and negatively affects…”
Get more information

Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS) by Chen, Chung-Hwan, Elsalmawy, Abdulaziz H., Ish-Shalom, Sophia, Lim, Seung-Jae, Al-Ali, Nadia S., Cunha-Borges, Joao L., Yang, Huilin, Casas, Noemí, Altan, Lale, Moll, Thomas, Gurbuz, Sirel, Brnabic, Alan J.M., Burge, Russel T., Marin, Fernando

“…Objective: To describe the study design and baseline patient characteristics of the Asia and Latin America Fracture Observational Study (ALAFOS) to better…”
Get full text

Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry by Yu, Chen, Wang, Gang, Burge, Russel T., Ye, Erjia, Dou, Guanshen, Li, Jinnan, Harrison, Ryan W., McLean, Robert R., Kerti, Samantha J., Bagel, Jerry

“…Introduction Real-world data are limited comparing Asian and White patients with psoriasis using biologic therapy. This study compared the 6-month…”
Get full text

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations by Tosteson, Anna N A, Burge, Russel T, Marshall, Deborah A, Lindsay, Robert

“…To evaluate the cost-effectiveness of osteoporosis treatments for women at high fracture risk and estimate the population-level impact of providing…”
Get full text

Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry by Lockshin, Benjamin, Harrison, Ryan W., McLean, Robert R., Crabtree, Margaux M., Konicek, Bruce W., Zhu, Baojin, Malatestinic, William N., Atiya, Bilal, Murage, Mwangi J., Burge, Russel T.

“…Introduction The aim of this work is to describe real-world biologic-experienced psoriasis patients initiating ixekizumab by prior biologic therapy status and…”
Get full text

Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry by Gulliver, Wayne P., See, Kyoungah, Zhu, Baojin, Konicek, Bruce W., Harrison, Ryan W., McLean, Robert R., Kerti, Samantha J., Burge, Russel T., Leonardi, Craig L.

“…Background Dermatologists would benefit from an easy to use psoriasis severity assessment tool in the clinic. Objective To develop psoriasis assessment tools…”
Get full text

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia by Graham-Clarke, Peita L, Hauber, Brett, Boeri, Marco, Leonardi, Felice, Burge, Russel T, Fernandez, Maria, Tockhorn-Heidenreich, Antje, Florez, Sandra

“…Teriparatide is used to treat patients with established osteoporosis but is often reserved for patients who have inadequate response to antiresorptive therapy…”
Get full text

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey by Zhang, Bin, Menzin, Joe, Friedman, Mark, Korn, Jonathan R., Burge, Russel T.

“…ABSTRACT Purpose: To assess the national prevalence of low levels of high-density lipoprotein cholesterol (HDL-C) among adults with coronary heart disease…”
Get full text

Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study by Hazel-Fernandez, Leslie, Louder, Anthony M, Foster, Shonda A, Uribe, Claudia L, Burge, Russel T

“…Improper medication adherence is associated with increased morbidity, healthcare costs, and fracture risk among patients with osteoporosis. The objective of…”
Get full text

Interstate Variation in the Burden of Fragility Fractures by King, Alison B, Tosteson, Anna NA, Wong, John B, Solomon, Daniel H, Burge, Russel T, Dawson‐Hughes, Bess

“…Demographic differences may produce interstate variation in the burden of osteoporosis. We estimated the burden of fragility fractures by race/ethnicity, age,…”
Get full text

Methodology for Estimating Current and Future Burden of Osteoporosis in State Populations: Application to Florida in 2000 through 2025 by Burge, Russel T., King, Alison B., Balda, Eric, Worley, Dan

“…The aging population is expected to increase the burden of osteoporosis on the US health-care system. We developed a methodology for estimating current and…”
Get full text

Attainment of combined optimal lipid values and the impact of lipid medication on cardiovascular outcomes and costs in a commercially insured population in the US by Quimbo, Ralph A, Simko, Robert J, Cziraky, Mark J, Burge, Russel T

“…To determine factors associated with the achievement of optimal lipid values (OLVs) and subsequent impact on clinical and economic outcomes. An observational…”
Get more information

Dyslipidemia Treatment in Diabetic Patients in a U.S. Managed Care Plan by Toth, Peter P, Laitinen, David L, Burge, Russel T, Shetty, Sharash

Get full text

Long-Term Treatment Patterns Among Patients With Psoriasis Treated With Ixekizumab or Adalimumab: A Real-World Study by Blauvelt, Andrew, Shi, Nianwen, Murage, Mwangi, Ridenour, Terri, Lew, Carolyn, Somani, Najwa, Zhu, Baojin, Zimmerman, Nicole, Kern, Scott, Burge, Russel

“…There is a paucity of long-term real-world evidence comparing the effectiveness of ixekizumab (IXE) and adalimumab (ADA). We compared real-world treatment…”
Get more information

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture by Harvey, N. C., Kanis, J. A., Odén, A., Burge, R. T., Mitlak, B. H., Johansson, H., McCloskey, E. V.

“…Summary Daily teriparatide injections have been shown to reduce vertebral and non-vertebral fractures. Here, we demonstrate that the magnitude of fracture risk…”
Get full text